MWNA
CERE

Marshall Wace North America’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Marshall Wace North America’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-48,583
Closed -$667K – 1802
2021
Q1 		$667K Sell
48,583
-145,219
-75% -$1.99M ﹤0.01% 1110
2020
Q4 		$3.21M Buy
+193,802
New +$3.21M 0.01% 640